MedTrace Logo

US Guided Axillary Block With Only One Injection

NCT02334176 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 320

Last updated 2015-01-08

No results posted yet for this study

Summary

The investigators conducted this prospective, randomized, observer-blinded, non-inferiority trial to compare single perivascular injection to double injection (musculocutaneous nerve and perivascular injection) US guided axillary brachial plexus block.

Conditions

  • Anesthesia

Interventions

PROCEDURE

Ultrasound guided axillary plexus block with 1 injection

The needle will be advanced until the tip is positioned just dorsal to the artery and 35ml of (lidocaine 1.5% with epinephrine 5µg/ml) is deposited in this location.

PROCEDURE

Ultrasound guided axillary plexus block with 2 injections

The needle will be initially advanced toward musculocutaneous nerve and 7 ml of LA (lidocaine 1.5% with epinephrine 5µg/ml) is deposited around the nerve. The needle will be then advanced until the tip is positioned just dorsal to the artery and 28 ml of (lidocaine 1.5% with epinephrine 5µg/ml) is deposited in this location.

DRUG

lidocaine 1.5% with epinephrine 5µg/ml

35 ml of lidocaine 1.5% with epinephrine 5µg/ml will be used to perform the axillary plexus block

Sponsors & Collaborators

  • Institut Kassab d'Orthopédie

    lead OTHER

Principal Investigators

  • Olfa Kaabachi, M.D · Kassab Institut of orthopedics

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2015-06-30
Completion
2015-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02334176 on ClinicalTrials.gov